Find uplifting stories about heroes, innovations, and solutions
65 results for "clinical trials"
After decades of managing HIV with complex multi-pill regimens, older patients may soon have access to a single daily pill that works just as well. A groundbreaking clinical trial shows the new treatment suppressed the virus in 96% of participants while also improving cholesterol levels.
Jennifer Ferris transformed a "Wild Wild West" research environment into a thriving 17-person operation, earning the first university-wide staff award ever given to UT Health Sciences' Knoxville campus. Her journey from solo clinical trial coordinator to award-winning director shows how one person's vision can reshape an entire research community.
The FDA just made it easier for millions of Americans with rare diseases to access life-saving gene therapies without waiting years for traditional clinical trials. Families who were told to "wait for science to catch up" now have real hope.
A silver Lab named Clarice beat cancer using an experimental treatment that's now paving the way for new immunotherapy options for children. The trial combined surgery, radiation, and immune-boosting injections to save her leg and her life.
China's brain-computer interface industry hit $530 million in 2025, racing ahead with government backing, fast clinical trials, and insurance coverage that's making the life-changing technology accessible to patients now. While others talk about the future, Chinese startups are already helping paralyzed patients control devices with their minds.
Doctors are implanting specially engineered stem cells directly into the brains of Parkinson's patients, hoping to restore dopamine production and reverse the disease's devastating symptoms. The breakthrough trial could transform treatment for over one million Americans living with the progressive disorder.
A promising new liver cancer treatment just received FDA Fast Track designation, potentially speeding up access for patients who need it most. The designation for PLT012 marks meaningful progress in the fight against one of the deadliest cancers.
A tongue-stimulating mouthpiece just got FDA approval to treat the phantom ringing that affects 25 million Americans. Clinical trials show 91% of users experienced major relief from their tinnitus symptoms.
A groundbreaking psilocybin-based therapy just moved closer to becoming the first psychedelic treatment approved for severe depression. Two major clinical trials showed the therapy significantly improved symptoms with just one or two doses.
A groundbreaking treatment for myotonic dystrophy type 1 reduced toxic proteins by 40% and improved muscle function in patients who've never had disease-modifying options. The New England Journal of Medicine just published results that could lead to the first approved therapy for this progressive, often fatal disease.
A Connecticut man became the first patient in his state to test a revolutionary medication that could slow Parkinson's progression by fighting brain inflammation. The breakthrough approach targets the disease differently than any treatment before it.
A second major clinical trial shows psilocybin therapy significantly reduces treatment-resistant depression. The breakthrough brings new hope to millions who haven't found relief from traditional antidepressants.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
Scientists discovered ketamine's power to treat alcohol addiction doesn't come from its psychedelic effects, opening new hope for understanding how the therapy actually works. The breakthrough challenges popular theories and points to brain rewiring as the real healing mechanism.
A single injection of experimental drug Axpaxli kept vision stable for up to a year in patients with age-related blindness, potentially reducing treatment burden. The Phase 3 trial showed significantly better durability than the current standard treatment.
A Connecticut man in his 50s became the first participant in a groundbreaking Parkinson's clinical trial at UConn Health after his wife spotted a recruitment flyer during a clinic visit. The study aims to improve outcomes for newly diagnosed patients through early intervention.
A psychedelic treatment could soon offer new hope for people with severe depression who haven't found relief from traditional medicines. Two major clinical trials show the psilocybin therapy helped patients improve more than standard care.
After years of promise, artificial intelligence in drug discovery faces its biggest test yet as the first AI-designed medications enter final-stage clinical trials. The results could either prove AI can revolutionize medicine or reveal the technology still has a long way to go.
A biomedical engineer at Georgia Tech is testing whether ski goggle-style lights and sound can slow Alzheimer's progression, offering hope for millions without the serious side effects of current drugs. Nearly 700 patients are now enrolled in a promising Phase 3 clinical trial.
Pharmaceutical giant Eli Lilly achieved positive results in nearly all its 2025 clinical trials, bringing new treatments for obesity, diabetes, and cancer closer to patients who need them. The company is also building the world's largest pharmaceutical AI supercomputer to speed up future drug discoveries.
Showing 20 of 65